In glioma cells, celastrol activates the cell death receptor pathway by increasing the expression levels of death receptor 5 (DR5), caspase-8, caspase-3, and PARP proteins, thereby inducing apoptosis 33. This evidence concerns the gene TNFRSF10B and central nervous system cancer.